Giant Biogene Holding Future Growth
Future criteria checks 6/6
Giant Biogene Holding is forecast to grow earnings and revenue by 23.4% and 20.9% per annum respectively. EPS is expected to grow by 22.6% per annum. Return on equity is forecast to be 34.1% in 3 years.
Key information
23.4%
Earnings growth rate
22.6%
EPS growth rate
| Personal Products earnings growth | 18.1% |
| Revenue growth rate | 20.9% |
| Future return on equity | 34.1% |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%
Aug 21
Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Recent updates
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%
Aug 21Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?
Aug 09Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear
Jul 01Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8,507 | 3,136 | 2,563 | 3,148 | 20 |
| 12/31/2025 | 6,694 | 2,522 | 2,086 | 2,507 | 21 |
| 12/31/2024 | 5,105 | 1,974 | 1,463 | 2,064 | 21 |
| 6/30/2024 | 4,459 | 1,768 | 1,670 | 1,877 | N/A |
| 3/31/2024 | 3,992 | 1,610 | 1,545 | 1,762 | N/A |
| 12/31/2023 | 3,524 | 1,452 | 1,419 | 1,647 | N/A |
| 9/30/2023 | 3,255 | 1,252 | 1,218 | 1,480 | N/A |
| 6/30/2023 | 2,985 | 1,052 | 1,016 | 1,313 | N/A |
| 3/31/2023 | 2,675 | 874 | 897 | 1,122 | N/A |
| 12/31/2022 | 2,364 | 696 | 778 | 932 | N/A |
| 12/31/2021 | 1,552 | 809 | 617 | 692 | N/A |
| 12/31/2020 | 1,190 | 826 | 758 | 834 | N/A |
| 12/31/2019 | 957 | 552 | 571 | 656 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2367's forecast earnings growth (23.4% per year) is above the savings rate (2.3%).
Earnings vs Market: 2367's earnings (23.4% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).
High Growth Earnings: 2367's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2367's revenue (20.9% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2367's revenue (20.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2367's Return on Equity is forecast to be high in 3 years time (34.1%)